U.S. Pharma Stock News

NasdaqGS:PLPC
NasdaqGS:PLPCElectrical

A Look At Preformed Line Products (PLPC) Valuation After Sales Growth And Profit Pressure

Preformed Line Products (PLPC) recently reported fourth quarter and full year 2025 results, showing higher net sales and a larger order backlog, alongside lower net income as tariffs and inventory adjustments weighed on profitability. See our latest analysis for Preformed Line Products. Preformed Line Products’ share price has climbed 23.08% year to date and its 1 year total shareholder return of 112.20% far outpaces the 90 day share price return of 12.54%. This suggests that momentum may...
NYSE:KSS
NYSE:KSSMultiline Retail

Is Kohl's (KSS) Share Slide Creating A Potential Value Opportunity For Investors

Wondering if Kohl's share price still reflects its true worth, or if the recent volatility has created a potential mispricing worth a closer look. The stock closed at US$13.27, with recent returns showing a 15.3% decline over 7 days and a 23.3% decline over 30 days, while the 1 year return sits at 68.4%. These swings sit against a longer backdrop where the 3 year return is a 29.8% decline and the 5 year return is a 70.3% decline. Short term moves can look very different from the longer track...
NYSE:HCI
NYSE:HCIInsurance

How Investors Are Reacting To HCI Group (HCI) Authorizing an $80 Million Share Buyback Program

On 3 March 2026, HCI Group, Inc. announced that its Board of Directors had authorized a one-year share repurchase program of up to US$80,000,000 of its common stock. This buyback authorization can be read as management choosing to allocate capital back to shareholders, potentially altering the company’s future capital structure and per-share metrics. We’ll now examine how HCI Group’s new US$80,000,000 repurchase authorization could influence its investment narrative and future capital...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

Trupanion HABRI Alliance Adds New Dimension To Pet Insurance Story

Trupanion (NasdaqGM:TRUP) announced a new partnership with the Human Animal Bond Research Institute (HABRI). The collaboration focuses on research and advocacy that supports the human and animal connection, including pet owners, veterans, service animals, and special populations. The initiative aims to use data driven insights to inform programs and policies that affect pet and human welfare. For you as an investor, this adds another layer to Trupanion's core pet insurance business. The...
NYSE:PATH
NYSE:PATHSoftware

UiPath (PATH) Profitability Milestone Tests Bearish Earnings Decline Narrative

UiPath (PATH) just posted its FY 2026 Q4 scorecard with revenue of US$481.1 million and basic EPS of US$0.19, alongside net income of US$104.5 million, putting a clear spotlight on how its automation platform is now feeding through to the bottom line. The company has seen quarterly revenue move from US$354.7 million in FY 2025 Q3 to US$423.6 million in FY 2025 Q4, then to US$356.6 million, US$361.7 million, US$411.1 million and now US$481.1 million in FY 2026 Q4. Basic EPS over those same...
NYSE:CLVT
NYSE:CLVTProfessional Services

Is Clarivate (CLVT) Pricing Catching Up After Recent 25.7% Share Price Jump?

This article walks through the key numbers so you can judge for yourself whether Clarivate's current share price reflects its true worth or if the market is still mispricing the story. Over the past month, Clarivate's share price is up 25.7%, although the stock still shows a 20.1% decline year to date and a 35.1% decline over the last year, with longer term returns over 3 and 5 years also in negative territory. Recent coverage around Clarivate has focused on its role as a data and analytics...
NYSE:KAI
NYSE:KAIMachinery

Is Kadant (KAI) Pricing Look Stretched After Recent Pullback In The Share Price

For investors wondering whether Kadant, at around US$321 per share, is priced for perfection or offering value, this article walks through what the numbers say about the stock. The share price is up 12.2% year to date. However, the past 7 days and 30 days show returns of 7.1% and 5.1% declines, and the 1 year return is a 4.5% decline, following a stronger 61.9% 3 year and 85.0% 5 year performance. Recent news coverage has focused on Kadant's role in capital goods markets and how investors...
NYSE:ABX
NYSE:ABXInsurance

Did Abacus Global Management's Earnings Turnaround Just Shift Abacus Global Management's (ABX) Investment Narrative?

Abacus Global Management, Inc. reported past fourth-quarter 2025 revenue of US$71.9 million, up from US$33.21 million a year earlier, and turned a prior net loss of US$18.26 million into net income of US$7.23 million, with basic earnings per share from continuing operations improving from a loss of US$0.22 to earnings of US$0.07. For 2025 as a whole, the company’s revenue more than doubled to US$235.24 million and it moved from a full-year net loss of US$23.96 million to net income of...
NYSE:OFG
NYSE:OFGBanks

A Look At OFG Bancorp’s (OFG) Valuation After Its New 2036 US$200 Million Bond Offering

Why the new 2036 bond matters for OFG Bancorp investors OFG Bancorp (OFG) has launched a US$200 million fixed to floating rate note offering due April 1, 2036, a move that could reshape its funding mix and draw attention to its capital structure. See our latest analysis for OFG Bancorp. The new 2036 notes come after a softer patch for the shares, with a 30 day share price return of 6.29% decline and year to date share price return of 4.44% decline. However, the 5 year total shareholder return...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Is Up 7.3% After CARVYKTI Reaches Profitability And 10,000 Patients Treated

In March 2026, Legend Biotech reported fourth-quarter 2025 revenue of US$306.3 million, up from US$186.5 million a year earlier, with an adjusted profit of US$0.01 per share but a GAAP net loss of US$30.9 million for the quarter and US$296.8 million for the full year on revenue of US$1.03 billion. The company’s CARVYKTI franchise reached more than 10,000 treated patients, achieved product-level profitability in 2025, and expanded to 294 treatment sites across 14 markets while scaling...
NYSEAM:BKTI
NYSEAM:BKTICommunications

BK Technologies (BKTI) Margin Expansion Reinforces Bullish Profitability Narratives

BK Technologies (BKTI) just posted fourth quarter FY 2025 revenue of US$21.5 million with basic EPS of US$1.12, alongside trailing 12 month revenue of US$86.1 million and EPS of US$3.69 that reflect the broader run rate coming into this report. The company has seen revenue move from US$17.9 million in Q4 2024 to US$21.5 million in Q4 2025, with basic EPS shifting from US$1.03 to US$1.12 over the same period, setting up a picture of earnings that feed into trailing 12 month net income of...
NYSE:MGY
NYSE:MGYOil and Gas

Magnolia Oil And Gas Reserves Growth Adds Weight To Production Story

Magnolia Oil & Gas (NYSE:MGY) has reported significant growth in its proved developing producing reserves. The company also highlighted continued increases in production levels. This operational update focuses on changes in Magnolia's resource base and output profile, rather than on valuation or analyst forecasts. For investors tracking NYSE:MGY, this reserve and production update adds fresh operational context to a share price that most recently closed at $28.94. The stock has returned...
NYSE:MWA
NYSE:MWAMachinery

Is Mueller Water Products (MWA) Attractive After Recent Pullback And DCF Valuation Gap

If you are wondering whether Mueller Water Products at about US$27.62 is offering fair value or a potential bargain, looking at how the stock is priced against its fundamentals can help you frame that question more clearly. The share price has eased in the short term, with a 4.5% decline over 7 days and a 6.2% decline over 30 days, while still sitting on a 15.4% gain year to date and a 6.1% return over the past year. These moves sit against a backdrop of ongoing interest in water...
NasdaqGS:HTO
NasdaqGS:HTOWater Utilities

Assessing H2O America (HTO) Valuation After Its Recent Share Price Momentum

What the recent move in H2O America means for investors H2O America (HTO) has quietly caught investor attention after its recent share price move, supported by positive 1-day, week, month, and past 3 months returns, prompting a closer look at its fundamentals. See our latest analysis for H2O America. With the share price at $57.36 and a 30-day share price return of 9.84% alongside a 90-day gain of 16.94%, short-term momentum looks stronger than the more modest 10.84% 1-year total shareholder...
NYSE:YELP
NYSE:YELPInteractive Media and Services

Is Yelp (YELP) Offering A Valuation Opportunity After Extended Share Price Weakness

If you are wondering whether Yelp's current share price lines up with its underlying business, this article will walk through what the numbers are really saying about its value. Yelp recently closed at US$24.05, with returns of a 0.9% decline over 7 days, 1.2% decline over 30 days, 20.4% decline year to date and 29.3% decline over 1 year. The 3 year and 5 year returns stand at 19.2% decline and 43.1% decline respectively. Recent attention on Yelp has been shaped by ongoing discussion around...
NYSE:MATX
NYSE:MATXShipping

Matson Leadership Shift And Cargo Security Move Reshape Commercial Outlook

Matson announced the upcoming retirement of Executive Vice President and Chief Commercial Officer John Lauer and named Chris Scott as his successor. The company outlined additional leadership promotions connected to this transition. Matson also launched a new cargo security initiative with BNSF Railway and War-Lok, adding multiple layers of protection for international intermodal cargo. Matson (NYSE:MATX) is pairing major leadership changes with an operational shift in how it protects...
NasdaqCM:LCNB
NasdaqCM:LCNBBanks

LCNB (LCNB) Net Margin Jump To 25.5% Tests Long Term Caution Narrative

LCNB (LCNB) closed out FY 2025 with fourth quarter revenue of US$22.3 million and basic EPS of US$0.40, while trailing twelve month figures showed revenue of US$90.1 million and EPS of US$1.63 as the bank reported net income of US$23.0 million over the period. Over recent reporting periods, revenue has moved from US$79.2 million and EPS of US$0.97 on a trailing basis at the end of 2024 to US$90.1 million and EPS of US$1.63 by the end of 2025, highlighting a period where net margins and...
NYSE:DQ
NYSE:DQSemiconductor

A Look At Daqo New Energy’s Valuation After Recent Share Price Swings

Why Daqo New Energy is on investors’ radar today Daqo New Energy (DQ) has caught investor attention after recent share price swings, with the stock showing mixed short term and longer term returns that raise fresh questions about how its current valuation lines up with fundamentals. See our latest analysis for Daqo New Energy. Recent trading has been choppy, with a 1 day share price return of 1.65% and 7 day gain of 3.90% sitting against a 90 day share price return decline of 27.25%. The 1...
NasdaqGS:KSPI
NasdaqGS:KSPIConsumer Finance

Assessing Kaspi.kz (NasdaqGS:KSPI) Valuation After Strong 2025 Earnings And Higher Quarterly Dividend Proposal

Kaspi.kz (NasdaqGS:KSPI) is in focus after proposing a quarterly dividend of KZT 850 per ADS and reporting fourth quarter and full year 2025 results that showed higher revenue and resilient annual net income. See our latest analysis for Kaspi.kz. Despite the solid revenue and dividend update, Kaspi.kz’s share price has been under pressure, with a 7 day share price return of a 4.72% decline and a year to date share price return of an 8.28% decline, while the 5 year total shareholder return...
NasdaqGM:GAMB
NasdaqGM:GAMBMedia

Gambling.com Group (GAMB) Q4 Margin Hit With US$26.9m Loss Tests Bullish Earnings Narratives

Gambling.com Group (GAMB) closed FY 2025 with Q4 revenue of US$46.2 million and a basic EPS loss of US$0.77, alongside a trailing twelve month basic EPS loss of US$0.93 on revenue of US$165.4 million. The company has seen quarterly revenue move from US$35.3 million and basic EPS of US$0.23 in Q4 2024 to US$46.2 million with a basic EPS loss of US$0.77 in Q4 2025, while trailing twelve month revenue shifted from US$127.2 million with basic EPS of US$0.85 in Q4 2024 to US$165.4 million with a...
NasdaqCM:IPSC
NasdaqCM:IPSCBiotechs

Century Therapeutics (IPSC) Swings To US$0.51 EPS Profit Challenging Persistent Loss Narratives

Century Therapeutics (IPSC) just posted FY 2025 results that put revenue at US$109.2 million with basic EPS of US$0.51 for the latest half, against a trailing twelve month profile that still shows a loss, with EPS of US$0.11 and net income of US$9.6 million in the red on US$109.2 million of revenue. Over the past year, the company has reported revenue of US$1.6 million and EPS of US$0.82 in early 2024, then US$4.96 million with EPS of US$0.79 in the second half of 2024, and then the latest...
NasdaqGS:ACDC
NasdaqGS:ACDCEnergy Services

ProFrac Holding (ACDC) Losses Deepen To US$369 Million TTM Reinforcing Bearish Narratives

ProFrac Holding (ACDC) closed out FY 2025 with fourth quarter revenue of US$436.5 million and a basic EPS loss of US$0.79, alongside net income excluding extra items of a US$142.6 million loss. Over the past few quarters, the company has seen revenue move from US$600.3 million and a basic EPS loss of US$0.12 in Q1 2025 to US$403.1 million and a basic EPS loss of US$0.60 in Q3 2025. Trailing twelve month figures show revenue at US$1.9 billion and a net loss of US$369 million, setting up a...
NasdaqGS:DSP
NasdaqGS:DSPSoftware

Viant Technology (DSP) Swings To Q4 Profit As 2.4% Net Margin Tests Bullish Narratives

Viant Technology (DSP) just closed out FY 2025 with fourth quarter revenue of US$110.1 million and basic EPS of US$0.49, alongside trailing 12 month revenue of US$344.2 million and EPS of US$0.51 that sit against a net profit margin of 2.4%. Over the past few quarters the company has seen revenue move from US$70.6 million in Q1 2025 to US$110.1 million in Q4 2025, with basic EPS ranging from a loss of US$0.07 in Q1 2025 to US$0.49 in Q4 2025. This gives investors a clearer view of how the...
NasdaqGM:CCLD
NasdaqGM:CCLDHealthcare Services

CareCloud (CCLD) Profitability Turn Challenges Dilution Focus After FY 2025 Earnings

CareCloud (CCLD) has capped FY 2025 with fourth quarter revenue of US$34.4 million and basic EPS of US$0.04, alongside trailing 12 month revenue of US$120.5 million and basic EPS of US$0.10, marking a clean move away from the losses seen earlier in the period. The company has seen quarterly revenue step up from US$27.4 million in Q2 2025 to US$34.4 million in Q4 2025, while quarterly basic EPS has shifted from a loss of US$0.04 in Q1 2025 to positive readings in each subsequent quarter,...